These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8636433)

  • 21. Amplification of T-cell receptor alpha- and beta-chain transcripts from mouse spleen lymphocytes by the nonpalindromic adaptor-polymerase chain reaction.
    Lin WL; Kuzmak J; Pappas J; Peng G; Chernajovsky Y; Platsoucas CD; Oleszak EL
    Hematopathol Mol Hematol; 1998; 11(2):73-88. PubMed ID: 9608356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
    Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K
    Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal expansion T cells identified in acute monoblastic leukemia by CDR3 size analysis of TCR V beta repertoire using RT-PCR and genescan.
    Li Y; Yang L; Chen S; Li R; Zhang Y; Lu Y; Luo G
    Chin Med J (Engl); 2002 Jan; 115(1):69-71. PubMed ID: 11930663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for preferential T cell receptor V beta gene usage and T cell clonal expansion in the synovium of BB rats with early-onset collagen-induced arthritis.
    Ye XJ; Aelion J; Endres RO; Kang AH; Cremer MA
    Cell Immunol; 1998 Feb; 183(2):81-9. PubMed ID: 9606991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substantial proportions of identical beta-chain T-cell receptor transcripts are present in epithelial ovarian carcinoma tumors.
    Pappas J; Jung WJ; Barda AK; Lin WL; Fincke JE; Purev E; Radu M; Gaughan J; Helm CW; Hernandez E; Freedman RS; Platsoucas CD
    Cell Immunol; 2005 Apr; 234(2):81-101. PubMed ID: 16038891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stable clonal expansion of the T-cell receptor V beta 6, V beta 17 and V beta 19 T cells in a cGVHD case using genescan analysis.
    Li Y; Du X; Xu M; Zhang T; Yang L; Chen S
    Chin Med J (Engl); 2001 May; 114(5):489-92. PubMed ID: 11780410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis.
    Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D
    J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CDR3 spectratyping and clonal expansion of peripheral blood T cells in a patient with beta-mediterranean anaemia following peripheral blood stem cell transplantation].
    Yao XS; Zhou MQ; Ma L; Luo W; Feng XQ; Wen Q; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):529-32. PubMed ID: 18495582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell clonal expansion in patients with B-cell lymphoproliferative disorders.
    Alatrakchi N; Farace F; Frau E; Carde P; Munck JN; Triebel F
    J Immunother; 1998 Sep; 21(5):363-70. PubMed ID: 9789198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma.
    Farace F; Angevin E; Escudier B; Caignard A; Dietrich PY; Genevee C; Hercend T; Triebel F
    Int J Cancer; 1993 Jul; 54(5):741-7. PubMed ID: 8325704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines.
    Farace F; Angevin E; Poullion I; Leboullaire C; Ferir G; Elias D; Escudier B; Triebel F
    Int J Cancer; 1997 Jun; 71(6):972-7. PubMed ID: 9185699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.
    Mosolits S; Markovic K; Fagerberg J; Frödin JE; Rezvany MR; Kiaii S; Mellstedt H; Jeddi-Tehrani M
    Cancer Immunol Immunother; 2005 Jun; 54(6):557-70. PubMed ID: 15570423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell receptor usage in malignant diseases.
    Halapi E; Jeddi-Tehrani M; Osterborg A; Mellstedt H
    Springer Semin Immunopathol; 1999; 21(1):19-35. PubMed ID: 10389230
    [No Abstract]   [Full Text] [Related]  

  • 34. Oligoclonal T cells in human cancer.
    Halapi E
    Med Oncol; 1998 Dec; 15(4):203-11. PubMed ID: 9951682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.
    Harville TO; Adams DM; Howard TA; Ware RE
    J Clin Immunol; 1997 Jul; 17(4):322-32. PubMed ID: 9258771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.
    Sensi M; Farina C; Maccalli C; Lupetti R; Nicolini G; Anichini A; Parmiani G; Berd D
    J Clin Invest; 1997 Feb; 99(4):710-7. PubMed ID: 9045874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.
    Kumar A; Farace F; Gaudin C; Triebel F
    J Clin Invest; 1996 Mar; 97(5):1219-26. PubMed ID: 8636433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ.
    De Keyser F; Elewaut D; Overmeer-Graus JP; Van den Broek P; Rijnders AW; Veys EM
    J Rheumatol; 1997 Sep; 24(9):1685-9. PubMed ID: 9292788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell receptor repertoire in neuroblastoma patients.
    Valteau D; Scott V; Carcelain G; Hartmann O; Escudier B; Hercend T; Triebel F
    Cancer Res; 1996 Jan; 56(2):362-9. PubMed ID: 8542593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J; Birck A; Straten PT
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):123-33. PubMed ID: 8744727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.